BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21955474)

  • 1. Matrix metalloproteinase 14 and 19 expression is associated with thoracic aortic aneurysms.
    Jackson V; Olsson T; Kurtovic S; Folkersen L; Paloschi V; Wågsäter D; Franco-Cereceda A; Eriksson P
    J Thorac Cardiovasc Surg; 2012 Aug; 144(2):459-66. PubMed ID: 21955474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves.
    Ikonomidis JS; Jones JA; Barbour JR; Stroud RE; Clark LL; Kaplan BS; Zeeshan A; Bavaria JE; Gorman JH; Spinale FG; Gorman RC
    J Thorac Cardiovasc Surg; 2007 Apr; 133(4):1028-36. PubMed ID: 17382648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase expression in the ascending aorta and aortic valve.
    Wilton E; Bland M; Thompson M; Jahangiri M
    Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):37-40. PubMed ID: 18025061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves.
    Boyum J; Fellinger EK; Schmoker JD; Trombley L; McPartland K; Ittleman FP; Howard AB
    J Thorac Cardiovasc Surg; 2004 Mar; 127(3):686-91. PubMed ID: 15001896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology.
    Lesauskaite V; Epistolato MC; Castagnini M; Urbonavicius S; Tanganelli P
    Hum Pathol; 2006 Aug; 37(8):1076-84. PubMed ID: 16867871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of TIMPs in ascending aorta aneurysms.
    Tsarouhas K; Soufla G; Apostolakis S; Zaravinos A; Panagiotou M; Khoury M; Hassoulas JA; Tsatsakis AM; Spandidos DA
    Thromb Res; 2010 Nov; 126(5):399-405. PubMed ID: 20863553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue microarray detection of matrix metalloproteinases, in diseased tricuspid and bicuspid aortic valves with or without pathology of the ascending aorta.
    Koullias GJ; Korkolis DP; Ravichandran P; Psyrri A; Hatzaras I; Elefteriades JA
    Eur J Cardiothorac Surg; 2004 Dec; 26(6):1098-103. PubMed ID: 15541969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves.
    LeMaire SA; Wang X; Wilks JA; Carter SA; Wen S; Won T; Leonardelli D; Anand G; Conklin LD; Wang XL; Thompson RW; Coselli JS
    J Surg Res; 2005 Jan; 123(1):40-8. PubMed ID: 15652949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas.
    Kondratiev S; Gnepp DR; Yakirevich E; Sabo E; Annino DJ; Rebeiz E; Laver NV
    Hum Pathol; 2008 Mar; 39(3):337-43. PubMed ID: 18045645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome.
    Segura AM; Luna RE; Horiba K; Stetler-Stevenson WG; McAllister HA; Willerson JT; Ferrans VJ
    Circulation; 1998 Nov; 98(19 Suppl):II331-7; discussion II337-8. PubMed ID: 9852923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatiotemporal patterns of smooth muscle cell changes in ascending aortic dilatation with bicuspid and tricuspid aortic valve stenosis: focus on cell-matrix signaling.
    Della Corte A; Quarto C; Bancone C; Castaldo C; Di Meglio F; Nurzynska D; De Santo LS; De Feo M; Scardone M; Montagnani S; Cotrufo M
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):8-18, 18.e1-2. PubMed ID: 18179910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms.
    Schmoker JD; McPartland KJ; Fellinger EK; Boyum J; Trombley L; Ittleman FP; Terrien C; Stanley A; Howard A
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):155-61. PubMed ID: 17198804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells.
    Lettau I; Hattermann K; Held-Feindt J; Brauer R; Sedlacek R; Mentlein R
    J Neuropathol Exp Neurol; 2010 Mar; 69(3):215-23. PubMed ID: 20142769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New signaling pathways from cancer progression modulators to mRNA expression of matrix metalloproteinases in breast cancer cells.
    Delassus GS; Cho H; Eliceiri GL
    J Cell Physiol; 2011 Dec; 226(12):3378-84. PubMed ID: 21344390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection.
    Ishii T; Asuwa N
    Hum Pathol; 2000 Jun; 31(6):640-6. PubMed ID: 10872655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta.
    Palombo D; Maione M; Cifiello BI; Udini M; Maggio D; Lupo M
    J Cardiovasc Surg (Torino); 1999 Apr; 40(2):257-60. PubMed ID: 10350113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms.
    McKellar SH; Tester DJ; Yagubyan M; Majumdar R; Ackerman MJ; Sundt TM
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):290-6. PubMed ID: 17662764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expressions of osteopontin and tenascin C in ascending aortic aneurysms are associated with trileaflet aortic valves as compared with bicuspid aortic valves.
    Majumdar R; Miller DV; Ballman KV; Unnikrishnan G; McKellar SH; Sarkar G; Sreekumar R; Bolander ME; Sundt TM
    Cardiovasc Pathol; 2007; 16(3):144-50. PubMed ID: 17502243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired splicing of fibronectin is associated with thoracic aortic aneurysm formation in patients with bicuspid aortic valve.
    Paloschi V; Kurtovic S; Folkersen L; Gomez D; Wågsäter D; Roy J; Petrini J; Eriksson MJ; Caidahl K; Hamsten A; Liska J; Michel JB; Franco-Cereceda A; Eriksson P
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):691-7. PubMed ID: 21148425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.